Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?
about
Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotypePathobiology of pulmonary arterial hypertension and right ventricular failureImmune and inflammatory mechanisms in pulmonary arterial hypertensionDNA Damage and Pulmonary HypertensionThe genetics of pulmonary arterial hypertensionWhole-exome sequencing reveals TopBP1 as a novel gene in idiopathic pulmonary arterial hypertensionTGFβ signalling in contextBone morphogenetic protein 4 enhances canonical transient receptor potential expression, store-operated Ca2+ entry, and basal [Ca2+]i in rat distal pulmonary arterial smooth muscle cellsPGC1α-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertensionSMAD proteins control DROSHA-mediated microRNA maturationBMP-9 induced endothelial cell tubule formation and inhibition of migration involves Smad1 driven endothelin-1 production.Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva.Multikinase inhibitor sorafenib prevents pressure overload-induced left ventricular hypertrophy in rats by blocking the c-Raf/ERK1/2 signaling pathway.Heritable forms of pulmonary arterial hypertension.BMP type II receptors have redundant roles in the regulation of hepatic hepcidin gene expression and iron metabolismGene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in ratsRegulation of bone morphogenetic protein 9 (BMP9) by redox-dependent proteolysis.BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathwaysA novel in vivo approach to assess radial and axial distensibility of large and intermediate pulmonary artery branchesCombination use of sildenafil and simvastatin increases BMPR-II signal transduction in rats with monocrotaline-mediated pulmonary hypertension.VIP and endothelin receptor antagonist: an effective combination against experimental pulmonary arterial hypertension.Molecular pathogenesis of pulmonary arterial hypertensionGenomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertensionDysfunctional intracellular trafficking in the pathobiology of pulmonary arterial hypertension.Pulmonary arterial hypertension: a disease of tethers, SNAREs and SNAPs?Novel approaches to pulmonary arterial hypertension drug discoveryGenetics of pulmonary arterial hypertension.Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females.Transdifferentiation of alveolar epithelial type II to type I cells is controlled by opposing TGF-β and BMP signalingRho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor gene.Pulmonary hypertension: therapeutic targets within the serotonin system.Defective pulmonary vascular remodeling in Smad8 mutant miceDiscerning functional hierarchies of microRNAs in pulmonary hypertension.Inflammatory mechanisms in the pathogenesis of pulmonary arterial hypertension.Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension.Oxidative injury is a common consequence of BMPR2 mutations.Molecular pathogenesis and current pathology of pulmonary hypertension.The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutationsCritical effects of epigenetic regulation in pulmonary arterial hypertension.Genetic and pharmacological inhibition of retinoic acid receptor γ function promotes endochondral bone formation.
P2860
Q24658407-17723313-C80B-4073-8016-6F5F78FFD4CFQ26821779-698FCC56-F8B2-48DF-81F2-4E97CA9B8B07Q26851508-1996E801-1182-43E2-BDDC-B7B329E638CCQ27005594-2A028FA4-FF31-4E46-81A1-E7C399A817A4Q27027507-88C9A996-867A-4FBD-ABCE-A7C39BED594FQ28237461-CF03ABC5-A533-40E6-8C94-C997DF89EB6AQ28275410-8352181D-5BDF-41D2-93CD-93509BAC073EQ28569097-813DF361-DE22-43B6-92F5-209CED2F2F91Q28578858-3D3C2AC2-9B83-49E8-9011-DB3D20100308Q28941771-248DE44D-FDD3-446B-A0EC-C4421EA13D2DQ31047574-0CA57721-B567-4A49-A47B-69F7ED01942FQ33685088-D2D93E14-A363-4A50-9B0C-D2F1B3730829Q33702040-EF2C8CEB-02D1-44DA-94D4-FB4A87E1D234Q33915567-0994D74B-6868-4B80-BD85-0CE5EC8F754CQ34293026-37044F5E-ABC5-40B1-8762-F3362E85BF4DQ34357126-2E157B8A-F2BE-4FE5-B70D-0589BEB85C94Q34467523-8E3C4B39-8753-4102-87F5-01D39B56CA30Q34483074-DE7D072A-BE47-47A6-BA47-17C1F4A1BD1DQ35062168-E6E293E1-2B1F-4CE3-86FB-DDBAFB828222Q35412283-6B87698C-1716-44FD-86D5-6D0A366B4AABQ35533520-D47287F9-56BA-4869-A2B9-9F246E67C0ABQ36736065-664F7175-01EE-42B9-AED5-AFF515213FF4Q36739882-BF697E77-501C-4B57-93F3-D4EE594457A0Q36761071-C60FBFB5-A8BA-4E75-811F-85D3C5D2F07CQ36784800-4791288D-C75C-422D-987C-D67B4999C987Q37066778-E425A17B-3192-4338-A929-8EF25716DECEQ37080526-110D2538-E1C8-40B2-AB03-9D6E4931589FQ37091591-2D30D20C-3940-4139-A2E6-B7A0803425BAQ37147106-356732F4-1192-433F-ABCA-EB9F793BF1C2Q37174962-EA20740B-B2C7-4E66-87AA-9E545FC90474Q37184405-0B41C0BB-76DE-4034-893F-E3C0E421F71FQ37252723-75030510-91CF-45F4-A073-98DB245C9572Q37677437-BD8C89A7-6DE9-4D2B-882B-BCEF07440C11Q38111730-361B4C82-EFF5-47A3-ACDA-E7C088081F13Q38112038-3C5E9FE7-9123-4164-9028-7E2CF2F7DF61Q38310428-50736025-5D73-431E-B627-B235793BD994Q38676413-FCB87040-ECF8-4A03-AADF-1D2513C66C95Q39152712-F2C874C0-2484-4F57-AF3D-3DF10F4FA9E8Q39345470-EA5B6EED-475D-4BF1-98E2-B7E343C826FFQ39668321-F889FBF4-0106-4242-812A-9B042A67EBDD
P2860
Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?
@ast
Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?
@en
type
label
Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?
@ast
Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?
@en
prefLabel
Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?
@ast
Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?
@en
P1476
Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?
@en
P304
P356
10.1513/PATS.200605-118SF
P577
2006-11-01T00:00:00Z